Octane Medical acquires B. Braun’s global orthobiologics business
Search Symbol
Plus symbol to reveal more information.

Safeguard Success

Octane CDMO

Octane CDMO Reutlingen, Germany

Protect Your ATMP’s Future Today

The ATMP landscape is complex and unforgiving. Every decision can either propel your therapy forward or set it back. To avoid costly delays, compliance roadblocks, and failure to reach market potential, you need a partner with a proven track record, deep expertise, and unwavering commitment.

Redefining What’s Possible in Cell Therapy

Octane exists on the cutting edge of cell therapy innovations and has the know-how, experience, technology, and systems to drive your vision forward with unmatched precision and expertise.

As an ATMP innovator, you seek advanced solutions. Octane equips you with cutting-edge automation, process optimization, and tools to push the boundaries of cell therapy.

“We are agile. Drawing on our expertise and tool sets, we will find the ideal solution to optimize your process and safeguard your vision.”

Detlef Schumann, CEO, Octane CDMO

Unrivalled ATMP Experience

As the first CDMO to develop and commercialize two in-house ATMPs, we have lived what it takes to drive complex, personalized cell therapies from concept to profitable global commercialization.

Harness  our hard-earned expertise in technology transfer, fully automated cell manufacturing, medical device development, and regulatory affairs to  safeguard your ATMP and propel it to global commercial success.

Fast-Track Your Path from Lab to Market

Let's Take the
Journey Together

You have the innovative ATMP.  Octane CDMO has the development and manufacturing expertise in personalized, complex cell therapies.  

Our team of 140 seasoned scientists, regulatory experts and manufacturing specialists is a highly efficient, automation-backed powerhouse that can run multiple projects simultaneously and deliver on a global scale.  Together, we can bring your innovation to market, and to patients around the world.

Specializing in
Complex, Personalized Therapies

We specialize in personalized cell and blood therapies, with proven expertise in:

Tissue Engineering

Blood Products

Automated Cell Culture

Bioreactors

Bio Sensors

Bio Printing & Organ Printing

Gene Modification

Cell Transfection

Automation: From
Biopsy to Final Product

We're the first CDMO to offer a fully closed automated cell manufacturing system—the Cocoon Automated Bioreactor—which delivers comprehensive end-to-end solutions. The Cocoon provides unique advantages for ATMP developers by integrating the highest number of sequential operations within a single automation platform, streamlining development and minimizing errors.

Be it with our system, or other leading automation systems, we’ll work with you to integrate automation early in the development process to save time, reduce costs, and prepare your therapy for scalable commercialization.

Automation Makes it Possible

Our advanced automation makes previously unviable solutions commercially feasible.

Automation Makes it Profitable

Introducing automation concepts early accelerates your timeline and reduces costs down the line.

Navigating Global
Regulatory Landscapes

Navigating regulatory approval is complex, but with our experience, you’ll have greater peace of mind. As the only CDMO with two marketed ATMPs and a global presence, we excel at managing relationships with regulators worldwide.

Expert Relationship Management

Our team routinely collaborates with local regulators to keep your project moving.

Proven Regulatory
Success

We have a history of securing approvals from leading authorities like the FDA and EMA.

International Clinical
Trials

We help set up and execute global clinical trials to ensure smooth completion.

Safeguard
Your Success

Our ATMP expertise, regulatory relationships and leadership in automation give you the edge to break through barriers and achieve exceptional results:

Safeguard Your Technology Transfer

Prevent costly missteps

Minimize delays

Minimize compliance issues

Reduce overall expenses

Seamless Technology Transfer

The highest product integrity and quality standards

Gain valuable time in the authorization process

Accelerate completion of clinical phases

Enable scalability for future growth

24+ Years of Driving Advancements
in Cell Therapy

With decades of experience, we have established ourselves as leaders in advanced cell and gene therapies. Here are just a few of the reasons why our partners trust us.

Two Marketed ATMPs Developed

Under our TETEC brand, we've manufactured over 30,000 cell therapy products for cartilage defects.

A Team of 140 Experts

Specializing in complex, personalized cell therapies and powered by best-in-class automation.

Proven Track Record

In executing large-scale clinical trials in the EU and US.

State-of-the-Art Facilities

Over 11,000 m² (120,000 ft²) GMP-compliant, multi-purpose facilities

Global Presence

Across Europe, the US, and Canada

$200 Million Investment

In advanced technologies for cell, biomaterial, and ATMP analysis

Quality Systems

Our quality protocols help make sure you’re on the right track – before you get too far on your ATMP development journey.

Standards-Based Validation

The ATMP development pathway can be perilous. Reduce  your risks with standards-based validation at every milestone.

Regulatory and Clinical Coordination

We simplify your ATMPs cross-border challenges with leading regulatory and clinical coordination.

International Presence

With CDMO facilities in Germany, USA and Canada, we are where you need us.

Germany

Reutlingen, BW

Canada

Kingston, ON

USA

Breinigsville, PA

CDMO

+

You

Connect with Octane CDMO Inc.

Safeguard every step of your ATMP’s journey to success.
Schedule a consultation with our experts at cdmo@octaneco.com.